• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (202)   Subscriber (50362)
For: Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health Aff (Millwood) 2018;35:2289-2296. [PMID: 27920318 DOI: 10.1377/hlthaff.2016.0623] [Citation(s) in RCA: 76] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Number Cited by Other Article(s)
1
LaBarca V. In case of emergency break glass: Reckoning with Project 2025. Public Health Nurs 2024. [PMID: 39194172 DOI: 10.1111/phn.13409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Accepted: 08/15/2024] [Indexed: 08/29/2024]
2
Piehl E, Veach S, Powers A, Otting R, Smith J, Polgreen LA, Wolff K, Witry MJ. Impact of outpatient pharmacist dispensing in an opioid use disorder clinic. J Am Pharm Assoc (2003) 2024;64:102094. [PMID: 38604475 DOI: 10.1016/j.japh.2024.102094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 03/20/2024] [Accepted: 04/05/2024] [Indexed: 04/13/2024]
3
Peterson LA, Andrews CM, Abraham AJ, Westlake MA, Grogan CM. Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits. Health Aff (Millwood) 2024;43:1038-1046. [PMID: 38950296 DOI: 10.1377/hlthaff.2023.01023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/03/2024]
4
Piehl E, Veach S, Powers A, Otting R, Smith J, Polgreen LA, Wolff K, Witry MJ. Reprint of: Impact of outpatient pharmacist dispensing in an opioid use disorder clinic. J Am Pharm Assoc (2003) 2024;64:102181. [PMID: 39152980 DOI: 10.1016/j.japh.2024.102181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 04/05/2024] [Indexed: 08/19/2024]
5
Soni A, Bullinger L, Andrews C, Abraham A, Simon K. The Impact of State Medicaid Eligibility and Benefits Policy on Neonatal Abstinence Syndrome Hospitalizations. CONTEMPORARY ECONOMIC POLICY 2024;42:25-40. [PMID: 38463202 PMCID: PMC10923531 DOI: 10.1111/coep.12623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Accepted: 07/28/2023] [Indexed: 03/12/2024]
6
Friedman LS, Abasilim C, Karch L, Jasmin W, Holloway-Beth A. Disparities in fatal and non-fatal opioid-involved overdoses among middle-aged non-Hispanic Black Men and Women. J Racial Ethn Health Disparities 2023:10.1007/s40615-023-01877-y. [PMID: 38048043 DOI: 10.1007/s40615-023-01877-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 11/10/2023] [Accepted: 11/20/2023] [Indexed: 12/05/2023]
7
Leech AA, McNeer E, Stein BD, Richards MR, McElroy T, Dupont WD, Patrick SW. County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder. Med Care 2023;61:816-821. [PMID: 37199507 PMCID: PMC10656358 DOI: 10.1097/mlr.0000000000001867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/19/2023]
8
Shoulders A, Andrews CM, Westlake MA, Abraham AJ, Grogan CM. Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021. JAMA HEALTH FORUM 2023;4:e232502. [PMID: 37566428 PMCID: PMC10422193 DOI: 10.1001/jamahealthforum.2023.2502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Accepted: 06/12/2023] [Indexed: 08/12/2023]  Open
9
Morris R, Rosenbaum S, Grogan C, Rhodes M, Andrews C. How Does Medicaid Managed Care Address the Needs of Beneficiaries with Opioid Use Disorders? A Deep Dive into Contract Design. AMERICAN JOURNAL OF LAW & MEDICINE 2023;49:339-348. [PMID: 38344786 PMCID: PMC11185417 DOI: 10.1017/amj.2023.35] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/15/2024]
10
Lindner SR, Hart K, Manibusan B, McCarty D, McConnell KJ. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees. JAMA HEALTH FORUM 2023;4:e231574. [PMID: 37351873 PMCID: PMC10290243 DOI: 10.1001/jamahealthforum.2023.1574] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 04/20/2023] [Indexed: 06/24/2023]  Open
11
Busch AB, Kennedy-Hendricks A, Schilling C, Stuart EA, Hollander M, Meiselbach MK, Barry CL, Huskamp HA, Eisenberg MD. Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder Care. Med Care 2023;61:314-320. [PMID: 36917776 PMCID: PMC10377507 DOI: 10.1097/mlr.0000000000001838] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/15/2023]
12
Farago F, Blue TR, Smith LR, Witte JC, Gordon M, Taxman FS. Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators. JOURNAL OF DRUG ISSUES 2023;53:296-320. [PMID: 38179102 PMCID: PMC10766435 DOI: 10.1177/00220426221109948] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2024]
13
McKnight ER, Dong Q, Brook DL, Hepler SA, Kline DM, Bonny AE. A Descriptive Study on Opioid Misuse Prevalence and Office-Based Buprenorphine Access in Ohio Prior to the Removal of the Drug Addiction Treatment Act of 2000 Waiver. Cureus 2023;15:e36903. [PMID: 37139287 PMCID: PMC10151104 DOI: 10.7759/cureus.36903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/30/2023] [Indexed: 04/03/2023]  Open
14
Crable EL, Grogan CM, Purtle J, Roesch SC, Aarons GA. Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol. Implement Sci Commun 2023;4:16. [PMID: 36797794 PMCID: PMC9936679 DOI: 10.1186/s43058-023-00396-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Accepted: 01/30/2023] [Indexed: 02/18/2023]  Open
15
Chang JE, Cronin CE, Lindenfeld Z, Pagán JA, Franz B. Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study. BMC Health Serv Res 2023;23:87. [PMID: 36703146 PMCID: PMC9877490 DOI: 10.1186/s12913-023-09035-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Accepted: 01/04/2023] [Indexed: 01/27/2023]  Open
16
Bell JS, Kang A, Benner S, Bhatia S, Jason LA. Predictors of Health in Substance Use Disorder Recovery: Economic Stability in Residential Aftercare Environments. JOURNAL OF SOCIAL WORK PRACTICE IN THE ADDICTIONS 2023;24:297-308. [PMID: 39268410 PMCID: PMC11390098 DOI: 10.1080/1533256x.2023.2170592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 11/25/2022] [Accepted: 11/28/2022] [Indexed: 09/15/2024]
17
Stewart RE, Cardamone NC, Mandell DS, Kwon N, Kampman KM, Knudsen HK, Tjoa CW, Marcus SC. Not in my treatment center: Leadership's perception of barriers to MOUD adoption. J Subst Abuse Treat 2023;144:108900. [PMID: 36265323 PMCID: PMC10062425 DOI: 10.1016/j.jsat.2022.108900] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 08/04/2022] [Accepted: 10/06/2022] [Indexed: 11/06/2022]
18
Abraham AJ, Andrews CM, Harris SJ, Westlake MM, Grogan CM. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care. JAMA HEALTH FORUM 2022;3:e224001. [PMID: 36331441 PMCID: PMC10157383 DOI: 10.1001/jamahealthforum.2022.4001] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
19
Smart R, Grant S, Gordon AJ, Pacula RL, Stein BD. Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder. JAMA HEALTH FORUM 2022;3:e223285. [PMID: 36218944 PMCID: PMC10041351 DOI: 10.1001/jamahealthforum.2022.3285] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]  Open
20
Prescription quantity and duration predict progression from acute to chronic opioid use in opioid-naïve Medicaid patients. PLOS DIGITAL HEALTH 2022;1:e0000075. [PMID: 36203857 PMCID: PMC9534483 DOI: 10.1371/journal.pdig.0000075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
21
Crable E, Jones DK, Walley AY, Hicks JM, Benintendi A, Drainoni ML. How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences. JOURNAL OF HEALTH POLITICS, POLICY AND LAW 2022;47:497-518. [PMID: 35044466 PMCID: PMC10688542 DOI: 10.1215/03616878-9716740] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
22
Suen LW, Makam AN, Snyder HR, Repplinger D, Kushel MB, Martin M, Nguyen OK. National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014-2018. J Gen Intern Med 2022;37:2420-2428. [PMID: 34518978 PMCID: PMC8436853 DOI: 10.1007/s11606-021-07069-w] [Citation(s) in RCA: 67] [Impact Index Per Article: 33.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 07/21/2021] [Indexed: 12/01/2022]
23
Samples H, Williams AR, Crystal S, Olfson M. Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes. J Subst Abuse Treat 2022;139:108774. [PMID: 35337716 PMCID: PMC9187597 DOI: 10.1016/j.jsat.2022.108774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 02/02/2022] [Accepted: 03/15/2022] [Indexed: 12/01/2022]
24
G Guerrero E, Amaro H, Khachikian T, Zahir M, Marsh JC. A bifurcated opioid treatment system and widening insidious disparities. Addict Behav 2022;130:107296. [PMID: 35255242 PMCID: PMC9078400 DOI: 10.1016/j.addbeh.2022.107296] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2021] [Revised: 01/24/2022] [Accepted: 02/26/2022] [Indexed: 11/20/2022]
25
Stritzel H. State-level changes in health insurance coverage and parental substance use-associated foster care entry. Soc Sci Med 2022;305:115042. [PMID: 35649299 PMCID: PMC10168186 DOI: 10.1016/j.socscimed.2022.115042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 05/09/2022] [Accepted: 05/13/2022] [Indexed: 11/24/2022]
26
Alegría M, Falgas-Bague I, Fukuda M, Zhen-Duan J, Weaver C, O’Malley I, Layton T, Wallace J, Zhang L, Markle S, Neighbors C, Lincourt P, Hussain S, Manseau M, Stein BD, Rigotti N, Wakeman S, Kane M, Evins AE, McGuire T. Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York. JAMA HEALTH FORUM 2022;3:e221771. [PMID: 35977217 PMCID: PMC9250047 DOI: 10.1001/jamahealthforum.2022.1771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2022] [Accepted: 04/28/2022] [Indexed: 11/14/2022]  Open
27
Giannouchos TV, Ukert B, Andrews C. Association of Medicaid Expansion With Emergency Department Visits by Medical Urgency. JAMA Netw Open 2022;5:e2216913. [PMID: 35699958 PMCID: PMC9198732 DOI: 10.1001/jamanetworkopen.2022.16913] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
28
van den Berk Clark C, Pickard JG, Drallmeier T. The role of age and opioid agonist treatment on substance use treatment completion in the United States. Aging Ment Health 2022;26:1295-1302. [PMID: 33999741 DOI: 10.1080/13607863.2021.1925223] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
29
Dickson-Gomez J, Weeks M, Green D, Boutouis S, Galletly C, Christenson E. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis. DRUG AND ALCOHOL DEPENDENCE REPORTS 2022;3:100051. [PMID: 36845978 PMCID: PMC9948907 DOI: 10.1016/j.dadr.2022.100051] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 03/24/2022] [Accepted: 03/28/2022] [Indexed: 11/18/2022]
30
Andraka-Christou B, Gordon AJ, Bouskill K, Smart R, Randall-Kosich O, Golan M, Totaram R, Stein BD. Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State Laws. J Addict Med 2022;16:192-207. [PMID: 34014209 PMCID: PMC8599526 DOI: 10.1097/adm.0000000000000863] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
31
Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuéllar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet 2022;399:555-604. [PMID: 35122753 PMCID: PMC9261968 DOI: 10.1016/s0140-6736(21)02252-2] [Citation(s) in RCA: 198] [Impact Index Per Article: 99.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 08/01/2021] [Accepted: 10/06/2021] [Indexed: 02/07/2023]
32
Crable EL, Benintendi A, Jones DK, Walley AY, Hicks JM, Drainoni ML. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment. Implement Sci 2022;17:3. [PMID: 34991638 PMCID: PMC8734202 DOI: 10.1186/s13012-021-01182-4] [Citation(s) in RCA: 31] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 12/15/2021] [Indexed: 11/26/2022]  Open
33
McClellan C, Moriya A, Simon K. Users of retail medications for opioid use disorders faced high out-of-pocket prescription spending in 2011-2017. J Subst Abuse Treat 2021;132:108645. [PMID: 34728135 DOI: 10.1016/j.jsat.2021.108645] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2021] [Revised: 10/01/2021] [Accepted: 10/09/2021] [Indexed: 11/26/2022]
34
Stancil SL, Abdel-Rahman S, Wagner J. Developmental Considerations for the Use of Naltrexone in Children and Adolescents. J Pediatr Pharmacol Ther 2021;26:675-695. [PMID: 34588931 DOI: 10.5863/1551-6776-26.7.675] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Accepted: 01/27/2021] [Indexed: 11/11/2022]
35
Zhen-Duan J, Fukuda M, DeJonckheere M, Falgas-Bagué I, Miyawaki S, Khazi P, Alegría M. Ensuring access to high-quality substance use disorder treatment for Medicaid enrollees: A qualitative study of diverse stakeholders' perspectives. J Subst Abuse Treat 2021;129:108511. [PMID: 34176694 PMCID: PMC8380648 DOI: 10.1016/j.jsat.2021.108511] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Revised: 02/01/2021] [Accepted: 05/26/2021] [Indexed: 11/24/2022]
36
Knudsen HK, Havens JR. Using conjoint analysis to study health policy changes: An example from a cohort of persons who use drugs. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2021;98:103425. [PMID: 34455174 DOI: 10.1016/j.drugpo.2021.103425] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Revised: 07/27/2021] [Accepted: 08/09/2021] [Indexed: 11/15/2022]
37
Pro G, Giano Z, Camplain R, Haberstroh S, Camplain C, Wheeler D, Hubach RD, Baldwin JA. The Role of State Medicaid Expansions in Integrating Comprehensive Mental Health Services into Opioid Treatment Programs: Differences Across the Rural/Urban Continuum. Community Ment Health J 2021;57:1017-1022. [PMID: 33033972 DOI: 10.1007/s10597-020-00719-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 10/01/2020] [Indexed: 02/03/2023]
38
Schuler MS, Dick AW, Stein BD. Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017. Drug Alcohol Depend 2021;223:108710. [PMID: 33873027 PMCID: PMC8204632 DOI: 10.1016/j.drugalcdep.2021.108710] [Citation(s) in RCA: 42] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 03/05/2021] [Accepted: 03/11/2021] [Indexed: 11/25/2022]
39
Barnes AJ, Cunningham PJ, Saxe-Walker L, Britton E, Sheng Y, Boynton M, Harper K, Harrell A, Bachireddy C, Montz E, Neuhausen K. Hospital Use Declines After Implementation Of Virginia Medicaid's Addiction And Recovery Treatment Services. Health Aff (Millwood) 2021;39:238-246. [PMID: 32011949 DOI: 10.1377/hlthaff.2019.00525] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
40
Samples H, Williams AR, Crystal S, Olfson M. Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid. Health Aff (Millwood) 2021;39:747-755. [PMID: 32364847 DOI: 10.1377/hlthaff.2019.01085] [Citation(s) in RCA: 40] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
41
Saloner B, Maclean JC. Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion. Health Aff (Millwood) 2021;39:453-461. [PMID: 32119615 DOI: 10.1377/hlthaff.2019.01428] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
42
Wen H, Druss BG, Saloner B. Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis. Health Aff (Millwood) 2021;39:740-746. [PMID: 32364856 DOI: 10.1377/hlthaff.2019.01021] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
43
Solomon KT, Bandara S, Reynolds IS, Krawczyk N, Saloner B, Stuart E, Connolly E. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis. J Subst Abuse Treat 2021;132:108424. [PMID: 34144299 DOI: 10.1016/j.jsat.2021.108424] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Revised: 04/14/2021] [Accepted: 04/15/2021] [Indexed: 11/25/2022]
44
Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada. PLoS One 2020;15:e0243317. [PMID: 33338065 PMCID: PMC7748134 DOI: 10.1371/journal.pone.0243317] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Accepted: 11/18/2020] [Indexed: 01/08/2023]  Open
45
Farnsworth CW, Lloyd M, Jean S. Opioid Use Disorder and Associated Infectious Disease: The Role of the Laboratory in Addressing Health Disparities. J Appl Lab Med 2020;6:180-193. [PMID: 33438735 DOI: 10.1093/jalm/jfaa150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 08/07/2020] [Indexed: 11/12/2022]
46
Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Private health insurance coverage of drug use disorder treatment: 2005-2018. PLoS One 2020;15:e0240298. [PMID: 33035265 PMCID: PMC7546457 DOI: 10.1371/journal.pone.0240298] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Accepted: 09/23/2020] [Indexed: 11/19/2022]  Open
47
Larochelle MR, Wakeman SE, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder: A Cohort Study. Med Care 2020;58:919-926. [PMID: 32842044 PMCID: PMC7641182 DOI: 10.1097/mlr.0000000000001394] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
48
Dale LM, Nosyk B. Commentary on Krawczyk et al. (2020): Reinforcing the case for evidence-based treatment of opioid use disorder. Addiction 2020;115:1695-1696. [PMID: 32293770 DOI: 10.1111/add.15045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Accepted: 03/11/2020] [Indexed: 11/29/2022]
49
Nelson KL, Purtle J. Factors associated with state legislators' support for opioid use disorder parity laws. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2020;82:102792. [PMID: 32540516 PMCID: PMC7483853 DOI: 10.1016/j.drugpo.2020.102792] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 04/30/2020] [Accepted: 05/15/2020] [Indexed: 12/23/2022]
50
Busch AB, Greenfield SF, Reif S, Normand SLT, Huskamp HA. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment. J Subst Abuse Treat 2020;115:108040. [PMID: 32600627 PMCID: PMC7687676 DOI: 10.1016/j.jsat.2020.108040] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2019] [Revised: 05/07/2020] [Accepted: 05/19/2020] [Indexed: 12/30/2022]
PrevPage 1 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA